Abdominal Compartment Syndrome (Surgical) — WSACS Definitions and Grades, Secondary Causes, Five-Arm Medical Management, Decompression, Open Abdomen and Fistula Arithmetic

Definition and guideline frame — 12 defines IAH, above 20 with new dysfunction defines ACS

Intra-abdominal hypertension is a sustained or repeated pathological elevation of intra-abdominal pressure (IAP) at or above 12 mmHg; the abdominal compartment syndrome is an IAP above 20 mmHg with evidence of organ dysfunction or failure.^[2] Normal baseline matters for calibration: IAP is approximately 5–7 mmHg in critically ill adults, so single-digit readings are physiology, not disease.^[1] The authority behind these lines is the 2013 World Society of the Abdominal Compartment Syndrome update, built from systematic or structured reviews through a modified Delphi for definitions and GRADE for management statements.^[1] Its headline split is worth memorizing exactly: RECOMMENDATIONS covered IAP measurement, avoidance of sustained IAH, protocolized monitoring and management, decompressive laparotomy for overt ACS, and negative-pressure wound therapy with same-hospital-stay fascial closure — while medical therapies and percutaneous drainage earned only SUGGESTIONS, and APP monitoring, diuretics, renal replacement, albumin and acute component separation earned NO RECOMMENDATION at all.^[1] Carry the honesty clause into every viva: the overall quality of evidence guiding those RECOMMENDATIONS was generally low.^[1]

Grades and perfusion arithmetic — I–IV bands and APP equals MAP minus IAP

WSACS grades IAH in four bands: Grade I 12–15 mmHg, Grade II 16–20 mmHg, Grade III 21–25 mmHg, and Grade IV above 25 mmHg.^[1] Perfusion arithmetic is APP = MAP − IAP.^[1] Two fences travel with these numbers. First, grades predict but do not prescribe: in the incidence systematic review, three of six studies found higher grades independently predicted mortality — an observational association, not a treatment threshold.^[3] Second, the APP equation does not make APP a target: the fluids review finds insufficient evidence to recommend APP as a resuscitation endpoint, and WSACS itself could make no recommendation on APP monitoring.^[16][1]

Subtypes — primary, secondary, recurrent, and the no-abdominal-injury trap

ACS is further classified as primary, secondary, or recurrent based on the duration and cause of the IAH-induced organ failure.^[2] Primary disease sits in the abdominopelvic region and frequently demands early surgical or radiological intervention; secondary disease originates outside the abdominopelvic region; recurrent disease redevelops after previous treatment of either.^[1] The viva trap is secondary ACS: severe burns are the textbook example — no primary intraperitoneal injury, yet severe IAH/ACS develops with progressive multi-organ dysfunction.^[24] It strikes burns above 60% body surface area especially hard when inhalation injury, delayed resuscitation, or abdominal-wall injury co-exist.^[24]

Epidemiology — common in ICU, wildly etiology-dependent, deadlier outside trauma

IAH is a routine ICU finding: across six studies using WSACS measurement (n = 1965), reported prevalence ran 30–49%, though definitions, measurement frequency and outcome reporting all varied.^[3] Zoom out to ACS itself and etiology dominates everything: total ACS incidence was 0.05% across 1,176,638 patients, spanning 15.16% in moderate/severe pancreatitis down to 0.22% in trauma — and the unadjusted mortality association ran from none in ECMO patients through OR 3.15 in trauma to OR 8.60 in nontrauma disease.^[4] In early septic shock (81 patients), 82.7% by maximal and 76.5% by mean IAP developed IAH; nonsurvivors ran higher pressures during shock (19.9 vs 17.2 mmHg), and surgical patients exceeded medical ones (93% vs 73%).^[5] In medical ICU patients stratified by risk factors, 57.6% carried two or more risk-factor categories, 67.8% of those developed IAH, and carrying two or more categories meant 41.4% versus 14.3% mortality.^[6] The surgical rule follows: incidence and mortality swing with etiology — ruptured aneurysm, pancreatitis, burns — so measure IAP in any surgical patient with risk factors.^[7]

Risk factors — fluids first, then the predisposing bundle and high-risk operations

Among surgical and trauma patients, aggressive fluid resuscitation is the most commonly reported risk factor for ACS — with ascites, hemoperitoneum, bowel distension and large tumours alongside, and damage-control surgery, ruptured-aneurysm repair and liver transplantation the higher-risk operations.^[29] The predisposing bundle to recite: sepsis, large-volume fluid resuscitation, polytransfusion, mechanical ventilation with high intrathoracic pressure, and acidosis.^[8] The ruptured-aneurysm lesson sharpens the monitoring point: ACS incidence ran approximately 5% unmonitored versus above 10% once IAP was monitored, with similar rates after open or endovascular repair — so recognized early, conservative treatment may still prevent ACS, while established ACS usually needs surgical decompression.^[13]

Pathophysiology — six-organ impairment, renal earliness, and the cardiac axis

Raised IAP impairs six systems — cardiac, pulmonary, renal, gastrointestinal, hepatic, and central nervous — and even small IAP rises degrade renal function, cardiac output, hepatic blood flow, respiratory mechanics, splanchnic perfusion and intracranial pressure.^[9][10] The kidney declares itself first: oliguria and acute kidney injury are early and frequent consequences, present even at relatively low IAP.^[8] The cardiac mechanism chain runs through venous return and the thorax: raised IAP reduces venous return, raises intrathoracic pressure, and impairs preload and contractility while increasing afterload — with the cardiovascular-renal-hepatic interplay now framed as the cardio-abdomino-renal syndrome.^[11]

Measurement — bladder gold standard, 25 mL ceiling, protocolized monitoring

Transduced bladder pressure is the gold standard for IAP — cheap, bedside, and correlating closely with directly measured abdominal pressures.^[8][10] Technique detail the examiner checks: WSACS caps intermittent bladder instillation at 25 mL of sterile saline, and in the 37-patient Kron comparison, 25 mL versus 10 mL agreed closely (concordance 0.95).^[12] Doctrine: monitor trans-bladder IAP in at-risk patients within protocolized monitoring and management — including vascular patients, where the 2013 additions of open-abdomen and lateralization definitions underline how seriously the post-rupture abdomen is taken.^[33][1]

Medical management — the five arms, started early with routine ICU tools

Nonoperative management is load-bearing, not adjunctive. The five treatment arms: improve abdominal-wall compliance, evacuate intraluminal contents, evacuate extraluminal fluid collections, optimize systemic and regional perfusion, and correct the positive fluid balance.^[14] Most of the toolkit is already routine ICU care — nasogastric and rectal tubes, prokinetics, enemas, sedation, body positioning — and it should be instigated early, before further organ dysfunction tips raised IAP into ACS.^[15] The guideline-grade specifics: brief trials of neuromuscular blockade as a temporizing measure (2D), and liberal enteral decompression with nasogastric or rectal tubes when stomach or colon are dilated (1D).^[1] The blockade case to quote as a case, never a rate: a 48-year-old at 40 mmHg normalized pressures with cisatracurium — hypoxia and renal function recovering — and avoided laparotomy entirely.^[19] The escalation ladder is explicit: sedation/analgesia, blockade, prokinetics, decompression tubes, fluid-balance interventions and percutaneous drainage first — urgent decompressive laparotomy only when ACS cannot otherwise be prevented or treated.^[18]

Fluids and perfusion — the positive-balance enemy and the pressor pivot

Secondary IAH tracks the fluid chart: evidence consistently ties it to a positive fluid balance, so restrictive, goal-directed resuscitation is the cornerstone — with early vasopressors and inotropes likely safe and helpful in cutting excess fluids in IAH.^[16] In burns this is doctrine: avoid over-resuscitation with large crystalloid volumes, and best evidence supports colloids or hypertonic saline once projected resuscitation volume passes a ceiling.^[26][25] Hold two fences. First, the fluid type remains unresolved and APP is not an endpoint — insufficient evidence for APP-targeted resuscitation, and no WSACS recommendation on APP monitoring, diuretics, renal replacement or albumin.^[16][1] Second, keep the Chest honesty clause verbatim in mind: nonsurgical steps (diuresis/dialysis, intraluminal evacuation, sedation) can be undertaken, although their clinical benefit remains largely conjectural — with minimal primary pathophysiology literature and few prospective randomized trials behind any of it.^[17]

Percutaneous drainage — the guideline suggestion and its two best datasets

WSACS SUGGESTS percutaneous catheter drainage for IAH/ACS, sitting in the ladder between maximal medical therapy and laparotomy.^[1][18] The burns pilot is the classic citation, fenced as a pilot: percutaneous drainage halted progression in five patients, but all four patients above 80% burns with severe inhalation injury failed to laparotomy — and every patient who needed laparotomy died of sepsis or respiratory failure.^[27] The paediatric series is the other anchor, fenced as retrospective single-centre: ultrasound-guided catheter drainage in 12 children with massive ascites significantly cut IAP, abdominal circumference and dysfunction indices.^[28]

Decompressive laparotomy — when, on whose authority, and at what price

Two authorities say operate once ACS is overt: WSACS recommends decompressive laparotomy for overt ACS in critically ill adults (1D), and EAST's sole level-I statement says documented ACS should undergo decompressive laparotomy.^[1][32] Midline laparotomy remains the standard ultimate treatment once ACS with organ dysfunction is established.^[17] The trauma before-after is the prevention story: as damage-control rates fell (39% to 8%) and crystalloids halved (12.8 to 6.6 L), ACS collapsed (7.4% to 0%) and mortality halved (22.8% to 10.6%) across 799 laparotomies — with crystalloid volume the only multivariate ACS predictor.^[30] The closure-technique warning from the damage-control cohort (52 patients): ACS complicated 17 cases, sharply raising ARDS/MOF (71% vs 31%) and death (35% vs 23%) — and primary fascial closure at the index laparotomy carried 80% ACS against 24% skin-only and 18% Bogotá bag, so avoid tight primary closure when ACS threatens.^[31] In pancreatitis, frame decompression as offered-not-proven: mortality stays 50–75% once ACS develops, most teams favour emergency xipho-pubic laparotomy with laparostomy only after maximal medical therapy fails or cardiorespiratory failure goes uncontrolled, and the ECMO series managed 3 survivors from 11 decompressions.^[20][22][41]

Open abdomen — definitions, closure systems, and what predicts failure

The 2013 update added open-abdomen and lateralization definitions with an OA classification system — the vocabulary of prolonged temporary closure.^[33] Across 106 papers, delayed fascial-closure rates ranked Wittmann patch (78%), dynamic retention sutures (71%) and VAC (61%) highest: Wittmann and VAC led without sepsis, VAC led with sepsis for both closure and mortality — all conclusions limited by heterogeneity.^[34] Modern doctrine favours negative-pressure temporary-closure systems on superior results, per both WSACS and EAST, with protocolized same-stay fascial-closure efforts.^[36][1] The 31-study prognostic review tells you who fails: enteral nutrition, organ dysfunction, local/systemic infection, re-explorations, rising injury severity and fistula formation delay definitive closure — while failed closure, large-bowel resection and 5–10 L of fluids within 48 hours predict enteroatmospheric fistula.^[35]

Enteroatmospheric fistula — rates, closure odds, and the lactate warning

In protocolized NPWT laparostomy care, 14% (8/57) developed enteroatmospheric fistulae.^[39] Closure arithmetic to carry: nutritional/clinical recovery in 85.7% with 18% healing spontaneously at median 57 days in the 77-patient series, and 61.3% closure at mean 46.7 days across 31 NPWT-managed fistulas.^[37][38] The warning number: preoperative arterial lactate above 3.5 mmol/L independently predicted fistula (OR 12.41), with mesenteric ischaemia as the co-signal — anastomose only revascularized bowel.^[39] The timing rule for counselling: most enteric fistulas that heal spontaneously do so within 4–6 weeks of conservative management; beyond that, surgery is indicated.^[40]

Secondary ACS deep cuts — pancreatitis, burns, and children

Pancreatitis carries the heaviest secondary-ACS burden: IAH in approximately 60–80% of severe disease with 27% ACS in the largest study (2009 review), or IAH 30–60% and ACS 15–30% of all acute pancreatitis (2023 review) — both marking severe disease with high morbidity and mortality.^[20][21] Define it the French way for precision: IAP above 20 mmHg with at least one organ-system failure, striking early in severe disease and potentially lethal in the very short term.^[22] Burns prevention is fluid discipline plus vigilance: continuous intra-vesical monitoring to guide resuscitation and catch secondary ACS early, capped volumes, and no crystalloid floods.^[25][26] Children run lower thresholds: ventilated normal IAP approximately 7 ± 3 mmHg, above 10 is IAH, and above 10 with new dysfunction is ACS until proven otherwise.^[23]

Exam pearls — thresholds, traps, and the evidence-honesty close

Carry five owned numbers. Thresholds: 12 defines IAH, above 20 with new dysfunction defines ACS, bands 12–15/16–20/21–25/above 25, APP = MAP − IAP.^[2][1] Measurement: bladder transduction is the gold standard, capped at 25 mL (10 mL equivalent at 0.95 concordance).^[8][12] Closure: tight primary fascial closure at damage control invites ACS (80%); Wittmann/VAC systems close most abdomens.^[31][34] Fistula: 14% with NPWT laparostomy, lactate above 3.5 warns (OR 12.41), 4–6 weeks then operate.^[39][40] And the honesty close the examiner rewards: guideline evidence generally low, nonsurgical benefit largely conjectural, few prospective trials — retire the 2004 line that laparotomy is the only treatment, because the modern ladder runs five medical arms and percutaneous drainage before the knife.^[1][17][10]

Revision summary

ACS is sustained IAP above 20 mmHg with new organ dysfunction, graded I–IV from 12 mmHg upward, with APP = MAP − IAP as arithmetic but not target.^[2][1] It is common in ICU (30–49% IAH) and lethally etiology-dependent (pancreatitis 15% ACS vs trauma 0.22%; nontrauma mortality OR 8.60).^[3][4] Fluids drive it, kidneys declare it early, bladder pressure detects it, and five medical arms plus percutaneous drainage precede the knife — with decompressive laparotomy reserved for overt ACS, negative-pressure temporary closure for the open abdomen, and lactate-watched fistula care after.^{[29][8][14][1]}

References41ShowHide

1. [1]Kirkpatrick AW, et al. Intra-abdominal hypertension and the abdominal compartment syndrome: updated consensus definitions and clinical practice guidelines from the World Society of the Abdominal Compartment Syndrome. Intensive Care Med, 2013.PMID 23673399
2. [2]Malbrain ML, et al. Results from the International Conference of Experts on Intra-abdominal Hypertension and Abdominal Compartment Syndrome. I. Definitions. Intensive Care Med, 2006.PMID 16967294
3. [3]Khot Z, et al. Incidence of Intra-Abdominal Hypertension and Abdominal Compartment Syndrome: A Systematic Review. J Intensive Care Med, 2021.PMID 31808368
4. [4]Larson NJ, et al. Etiology Matters: A Systematic Review and Meta-Analysis of Incidence and Outcomes in Abdominal Compartment Syndrome. J Intensive Care Med, 2026.PMID 42709742
5. [5]Regueira T, et al. Intra-abdominal hypertension: incidence and association with organ dysfunction during early septic shock. J Crit Care, 2008.PMID 19056007
6. [6]Santa-Teresa P, et al. Incidence and prognosis of intra-abdominal hypertension in critically ill medical patients: a prospective epidemiological study. Ann Intensive Care, 2012.PMID 22873419
7. [7]Björck M, et al. Intra-abdominal hypertension and abdominal compartment syndrome in nontrauma surgical patients. Am Surg, 2011.PMID 21944455
8. [8]Mohmand H, et al. Renal dysfunction associated with intra-abdominal hypertension and the abdominal compartment syndrome. J Am Soc Nephrol, 2011.PMID 21310818
9. [9]Cheatham ML, et al. Abdominal compartment syndrome: pathophysiology and definitions. Scand J Trauma Resusc Emerg Med, 2009.PMID 19254364
10. [10]Hunter JD, et al. Intra-abdominal hypertension and the abdominal compartment syndrome. Anaesthesia, 2004.PMID 15310355
11. [11]Soliman Aboumarie H, et al. Cardiovascular effects of intra-abdominal hypertension: current perspectives. Anaesthesiol Intensive Ther, 2025.PMID 41362929
12. [12]Hunt L, et al. A comparison of fluid instillation volumes to assess intra-abdominal pressure using Kron's methods. J Trauma Acute Care Surg, 2012.PMID 22710774
13. [13]Björck M, et al. The clinical importance of monitoring intra-abdominal pressure after ruptured abdominal aortic aneurysm repair. Scand J Surg, 2008.PMID 18575040
14. [14]De Keulenaer BL, et al. Nonoperative management of intra-abdominal hypertension and abdominal compartment syndrome: evolving concepts. Am Surg, 2011.PMID 21944450
15. [15]De Keulenaer B, et al. What's new in medical management strategies for raised intra-abdominal pressure: evacuating intra-abdominal contents, improving abdominal wall compliance, pharmacotherapy, and continuous negative extra-abdominal pressure. Anaesthesiol Intensive Ther, 2015.PMID 25421926
16. [16]Regli A, et al. Fluid therapy and perfusional considerations during resuscitation in critically ill patients with intra-abdominal hypertension. Anaesthesiol Intensive Ther, 2015.PMID 25421925
17. [17]Rogers WK, et al. Intraabdominal Hypertension, Abdominal Compartment Syndrome, and the Open Abdomen. Chest, 2018.PMID 28780148
18. [18]Roberts DJ, et al. Increased pressure within the abdominal compartment: intra-abdominal hypertension and the abdominal compartment syndrome. Curr Opin Crit Care, 2016.PMID 26844989
19. [19]Chiles KT, et al. Abdominal compartment syndrome successfully treated with neuromuscular blockade. Indian J Anaesth, 2011.PMID 22013257
20. [20]De Waele JJ, et al. Intra-abdominal hypertension in acute pancreatitis. World J Surg, 2009.PMID 19350318
21. [21]Jena A, et al. Intra-abdominal hypertension and abdominal compartment syndrome in acute pancreatitis. Indian J Gastroenterol, 2023.PMID 37418050
22. [22]Siebert M, et al. Management of abdominal compartment syndrome in acute pancreatitis. J Visc Surg, 2021.PMID 33516625
23. [23]De Waele JJ, et al. Intra-abdominal hypertension and abdominal compartment syndrome in pancreatitis, paediatrics, and trauma. Anaesthesiol Intensive Ther, 2015.PMID 25973660
24. [24]Kirkpatrick AW, et al. Intraabdominal hypertension and the abdominal compartment syndrome in burn patients. World J Surg, 2009.PMID 19350317
25. [25]Azzopardi EA, et al. Fluid resuscitation in adults with severe burns at risk of secondary abdominal compartment syndrome--an evidence based systematic review. Burns, 2009.PMID 19477594
26. [26]Malbrain ML, et al. Intra-abdominal hypertension and abdominal compartment syndrome in burns, obesity, pregnancy, and general medicine. Anaesthesiol Intensive Ther, 2015.PMID 25973659
27. [27]Latenser BA, et al. A pilot study comparing percutaneous decompression with decompressive laparotomy for acute abdominal compartment syndrome in thermal injury. J Burn Care Rehabil, 2002.PMID 12032369
28. [28]Liang YJ, et al. Controlled peritoneal drainage improves survival in children with abdominal compartment syndrome. Ital J Pediatr, 2015.PMID 25881886
29. [29]Leon M, et al. Abdominal compartment syndrome among surgical patients. World J Gastrointest Surg, 2021.PMID 33968300
30. [30]Joseph B, et al. The conjoint effect of reduced crystalloid administration and decreased damage-control laparotomy use in the development of abdominal compartment syndrome. J Trauma Acute Care Surg, 2014.PMID 24398772
31. [31]Offner PJ, et al. Avoidance of abdominal compartment syndrome in damage-control laparotomy after trauma. Arch Surg, 2001.PMID 11387007
32. [32]Diaz JJ Jr, et al. The management of the open abdomen in trauma and emergency general surgery: part 1-damage control. J Trauma, 2010.PMID 20539186
33. [33]Björck M, et al. Management of abdominal compartment syndrome and the open abdomen. Eur J Vasc Endovasc Surg, 2014.PMID 24447530
34. [34]Quyn AJ, et al. The open abdomen and temporary abdominal closure systems--historical evolution and systematic review. Colorectal Dis, 2012.PMID 22487141
35. [35]Cristaudo AT, et al. Treatments and other prognostic factors in the management of the open abdomen: a systematic review. J Trauma Acute Care Surg, 2017.PMID 27918375
36. [36]Afsar L, et al. Narrative Review of Open Abdomen Management and Comparison of Different Temporary Abdominal Closure Techniques. J Abdom Wall Surg, 2025.PMID 40556709
37. [37]Wainstein DE, et al. Management of enteroatmospheric fistula: a ten-year experience following fifteen years of learning. Surgery, 2023.PMID 36653234
38. [38]Bobkiewicz A, et al. Management of enteroatmospheric fistula with negative pressure wound therapy in open abdomen treatment: a multicentre observational study. Int Wound J, 2017.PMID 27000995
39. [39]Giudicelli G, et al. Prognostic Factors for Enteroatmospheric Fistula in Open Abdomen Treated with Negative Pressure Wound Therapy: a Multicentre Experience. J Gastrointest Surg, 2017.PMID 28536807
40. [40]Pepe G, et al. Entero-Cutaneous and Entero-Atmospheric Fistulas: Insights into Management Using Negative Pressure Wound Therapy. J Clin Med, 2024.PMID 38592102
41. [41]Glowka TR, et al. Decompressive laparotomy for the treatment of the abdominal compartment syndrome during extracorporeal membrane oxygenation support. J Crit Care, 2018.PMID 30096634